By Jon Hill ( August 15, 2017, 8:40 PM EDT) -- A proposed class of Theranos Inc. investors is moving forward with a securities fraud suit against the health technology startup after losing a bid to pause the company's settlements with Walgreen Co. and others, deals the investors called a "preferential transfer of assets."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.